sparsentan will reduce the extent or effect of modafinil by impacting hepatic enzyme CYP2C19 metabolism. Use Warning/Check. Sparsentan (a CYP2C19 inducer) decreases exposure of CYP2C19 substrates and minimizes efficacy connected to these substrates. Drug Interactions Whilst specific medicines should not be made use of collectively in the least, in https://waylonhloqr.ssnblog.com/25861486/not-known-details-about-modafinil